APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-steroidal Anti-inflammatory Drugs (NSAID)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025186 pages

Choose your research edition.

Industry ResearchNon-steroidal Anti-inflammatory Drugs (NSAID) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-steroidal Anti-inflammatory Drugs (NSAID) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-steroidal Anti-inflammatory Drugs (NSAID) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-steroidal Anti-inflammatory Drugs (NSAID) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-steroidal Anti-inflammatory Drugs (NSAID) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-steroidal Anti-inflammatory Drugs (NSAID) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Merck Animal Health, Bayer, Zoetis, St. Joseph, Merial, Generic, Elanco, Ecotrin and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-steroidal Anti-inflammatory Drugs (NSAID) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-steroidal Anti-inflammatory Drugs (NSAID) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-steroidal Anti-inflammatory Drugs (NSAID) market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Company

Merck Animal Health

Bayer

Zoetis

St. Joseph

Merial

Generic

Elanco

Ecotrin

Boehringer Ingelheim

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type

Propionic acid derivatives

Sulfonanilides

Anthranilic acid derivatives (Fenamates)

Salicylates

Enolic acid (Oxicam) derivatives

Selective COX-2 inhibitors (Coxibs)

Acetic acid derivatives

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application

Human

Animals

Others

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-steroidal Anti-inflammatory Drugs (NSAID) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-steroidal Anti-inflammatory Drugs (NSAID).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-steroidal Anti-inflammatory Drugs (NSAID) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Drivers Table 3. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Opportunities and Challenges Table 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Restraints Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers Table 9. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers, Product Type & Application Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Propionic acid derivatives Table 17. Major Manufacturers of Sulfonanilides Table 18. Major Manufacturers of Anthranilic acid derivatives (Fenamates) Table 19. Major Manufacturers of Salicylates Table 20. Major Manufacturers of Enolic acid (Oxicam) derivatives Table 21. Major Manufacturers of Selective COX-2 inhibitors (Coxibs) Table 22. Major Manufacturers of Acetic acid derivatives Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2026) Table 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2027-2032) Table 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (W Units) Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (W Units) Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2026) Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Human Table 34. Major Manufacturers of Animals Table 35. Major Manufacturers of Others Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2026) Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2027-2032) Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (W Units) Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (W Units) Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2026) Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2027-2032) Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2026) & (W Units) Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2021-2026) Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 53. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 54. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 56. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 63. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2021-2026) Table 67. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2027-2032) Table 68. Merck Animal Health Company Information Table 69. Merck Animal Health Business Overview Table 70. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 72. Merck Animal Health Recent Development Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 77. Bayer Recent Development Table 78. Zoetis Company Information Table 79. Zoetis Business Overview Table 80. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 82. Zoetis Recent Development Table 83. St. Joseph Company Information Table 84. St. Joseph Business Overview Table 85. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 87. St. Joseph Recent Development Table 88. Merial Company Information Table 89. Merial Business Overview Table 90. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 92. Merial Recent Development Table 93. Generic Company Information Table 94. Generic Business Overview Table 95. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 97. Generic Recent Development Table 98. Elanco Company Information Table 99. Elanco Business Overview Table 100. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 102. Elanco Recent Development Table 103. Ecotrin Company Information Table 104. Ecotrin Business Overview Table 105. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 107. Ecotrin Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List Table 116. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Image Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2021-2032) & (W Units) Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Propionic acid derivatives Image Figure 9. Sulfonanilides Image Figure 10. Anthranilic acid derivatives (Fenamates) Image Figure 11. Salicylates Image Figure 12. Enolic acid (Oxicam) derivatives Image Figure 13. Selective COX-2 inhibitors (Coxibs) Image Figure 14. Acetic acid derivatives Image Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2032) Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2032) Figure 21. Human Image Figure 22. Animals Image Figure 23. Others Image Figure 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2032) Figure 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2032) Figure 30. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2021-2032) Figure 32. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2021-2032) Figure 37. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2021-2032) Figure 44. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2021-2032) Figure 52. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Figure 63. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Figure 65. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Propionic acid derivatives
  • Sulfonanilides
  • Anthranilic acid derivatives (Fenamates)
  • Salicylates
  • Enolic acid (Oxicam) derivatives
  • Selective COX-2 inhibitors (Coxibs)
  • Acetic acid derivatives
Applications
  • Human
  • Animals
  • Others
Companies covered
  • Merck Animal Health
  • Bayer
  • Zoetis
  • St. Joseph
  • Merial
  • Generic
  • Elanco
  • Ecotrin
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Dynamics
  1. 2.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
  2. 2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Drivers
  3. 2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Opportunities and Challenges
  4. 2.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Restraints
3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Manufacturers
  1. 3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers, Product Type & Application
  7. 3.7 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-steroidal Anti-inflammatory Drugs (NSAID) Tier 1, Tier 2, and Tier 3
4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Type
  1. 4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Type Introduction
  2. 4.1.1 Propionic acid derivatives
  3. 4.1.2 Sulfonanilides
  4. 4.1.3 Anthranilic acid derivatives (Fenamates)
  5. 4.1.4 Salicylates
  6. 4.1.5 Enolic acid (Oxicam) derivatives
  7. 4.1.6 Selective COX-2 inhibitors (Coxibs)
  8. 4.1.7 Acetic acid derivatives
  9. 4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type
  10. 4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
  12. 4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2032)
  13. 4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type
  14. 4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
  16. 4.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2032)
5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Application
  1. 5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Animals
  4. 5.1.3 Others
  5. 5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application
  6. 5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
  8. 5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application
  10. 5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2032)
6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
  1. 6.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2032)
  3. 6.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2026)
  4. 6.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
  1. 7.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
  2. 7.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032)
  8. 7.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032)
  11. 7.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Animal Health
  2. 8.1.1 Merck Animal Health Company Information
  3. 8.1.2 Merck Animal Health Business Overview
  4. 8.1.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  6. 8.1.5 Merck Animal Health Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 St. Joseph
  20. 8.4.1 St. Joseph Company Information
  21. 8.4.2 St. Joseph Business Overview
  22. 8.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  24. 8.4.5 St. Joseph Recent Developments
  25. 8.5 Merial
  26. 8.5.1 Merial Company Information
  27. 8.5.2 Merial Business Overview
  28. 8.5.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  30. 8.5.5 Merial Recent Developments
  31. 8.6 Generic
  32. 8.6.1 Generic Company Information
  33. 8.6.2 Generic Business Overview
  34. 8.6.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  36. 8.6.5 Generic Recent Developments
  37. 8.7 Elanco
  38. 8.7.1 Elanco Company Information
  39. 8.7.2 Elanco Business Overview
  40. 8.7.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  42. 8.7.5 Elanco Recent Developments
  43. 8.8 Ecotrin
  44. 8.8.1 Ecotrin Company Information
  45. 8.8.2 Ecotrin Business Overview
  46. 8.8.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  48. 8.8.5 Ecotrin Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain Analysis
  2. 9.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
  6. 9.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
  9. 9.2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst